Beijing University of Chinese Medicine, Beijing 100029, China; The DongFang Hospital of Beijing University of Chinese Medicine, Beijing 100078, China.
The DongFang Hospital of Beijing University of Chinese Medicine, Beijing 100078, China.
Biomed Pharmacother. 2022 Sep;153:113437. doi: 10.1016/j.biopha.2022.113437. Epub 2022 Jul 21.
Anxiety is a common comorbidity of cardiovascular diseases, which deteriorated cardiac function. Chaihujialonggumulitang (BFG) was reported to have antioxidant properties, alleviate myocardial ischemia injury and improve anxiety-like behavior. The Nuclear factor erythroid 2-related factor 2 (Nrf2) /heme oxygenase-1 (HO-1) pathway is the main mechanism to defend against oxidative stress, and improve cardiac function. This study was to investigate the possible mechanism of BFG in the treatment of psycho-cardiology.
AMI with comorbid anxiety rat model was established by ligation of the left anterior descending coronary artery combined with uncertain empty bottle stimulation, followed by the administration of BFG (1 mL/100 g/d by gavage) or Dimethyl fumarate (DMF, 10 mg/kg/d by intraperitoneal injection) for 6 days. Echocardiography, myocardial injury markers, H&E, and Masson staining were employed to evaluate cardiac function. Behavioral tests and hippocampus neurotransmitters were applied to record anxiety-like behavior. We employed immunohistochemistry, RT-PCR, western blotting, and biochemical analysis to detect the protein and gene expression of Nrf2/HO-1 pathway-related factors, and oxidative stress and apoptosis parameters.
Rats in the AMI and complex groups showed cardiac function deterioration, as well as anxiety-like behavior. BFG improved echocardiography indicators, reduced myocardial injury markers, and attenuated myocardial pathological changes. BFG also ameliorated anxiety-like behaviors and elevated neurotransmitters levels. BFG promoted the activation of Nrf2/HO-1 pathway, increased antioxidant enzyme activities, reduced lipid peroxidation levels, and alleviated oxidative damage and apoptosis. DMF showed therapeutic effects and molecular mechanisms similar to BFG.
BFG may possess a psycho-cardiology therapeutic effect on AMI with comorbid anxiety by the activation of the Nrf2/HO-1 pathway and suppression of oxidative stress and apoptosis.
焦虑是心血管疾病的常见合并症,会恶化心脏功能。柴黄降粘颗粒(BFG)具有抗氧化特性,可减轻心肌缺血损伤并改善焦虑样行为。核因子红细胞 2 相关因子 2(Nrf2)/血红素加氧酶-1(HO-1)途径是抵御氧化应激和改善心脏功能的主要机制。本研究旨在探讨 BFG 治疗精神心脏病的可能机制。
通过结扎左前降支冠状动脉结合不确定空瓶刺激建立伴有焦虑的 AMI 大鼠模型,随后给予 BFG(灌胃 1 mL/100 g/d)或富马酸二甲酯(DMF,腹腔注射 10 mg/kg/d)治疗 6 天。采用超声心动图、心肌损伤标志物、H&E 和 Masson 染色评估心脏功能。行为测试和海马神经递质用于记录焦虑样行为。我们采用免疫组织化学、RT-PCR、western blot 和生化分析检测 Nrf2/HO-1 途径相关因子、氧化应激和细胞凋亡参数的蛋白和基因表达。
AMI 和复合组大鼠出现心脏功能恶化和焦虑样行为。BFG 改善了超声心动图指标,降低了心肌损伤标志物,减轻了心肌病理变化。BFG 还改善了焦虑样行为并提高了神经递质水平。BFG 促进了 Nrf2/HO-1 途径的激活,增加了抗氧化酶的活性,降低了脂质过氧化水平,并减轻了氧化损伤和细胞凋亡。DMF 表现出与 BFG 相似的治疗效果和分子机制。
BFG 通过激活 Nrf2/HO-1 途径和抑制氧化应激和细胞凋亡,可能对伴有焦虑的 AMI 具有精神心脏治疗作用。